.AstraZeneca executives state they are "not troubled" that the failure of tozorakimab in a period 2 ...
.Invite to today's Chutes & Ladders, our roundup of substantial leadership hirings, firings and a...
.After showing plans to attack the USA public markets lower than a month earlier, Zenas Biopharma as...
.Psyence Biomedical is actually paying for $500,000 in allotments to acquire fellow psilocybin-based...
.5 months after accepting Energy Therapeutics' Pivya as the very first brand new therapy for simple ...
.Eli Lilly has actually sprung right into an AI-enabled drug breakthrough deal, partnering along wit...
.Lykos CEO and also owner Amy Emerson is quiting, with chief operating policeman Michael Mullette ta...
.Novartis levels a brand-new outpost in its cooperation along with Voyager Rehabs, paying $15 millio...
.On the heels of an FDA denial for its primary rivalrous Novo Nordisk, Eli Lilly is making headway i...
.Just a handful of months after application the initial client in a period 2 test for newly identifi...